AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
IsoRay Medical Inc begins production testing of its proprietary Cesium-131 isotope through agreement with Idaho National Laboratory.
(From Chemical Business NewsBase - Press Release)
IsoRay Medical Inc's collaboration with Idaho National Laboratory took a major step on 27 Jun 2006 when testing began to demonstrate production of Cesium-131, the company's proprietary isotope currently used to treat prostate cancer. IsoRay Medical Inc is a wholly owned subsidiary of a public company, IsoRay Inc. It is the sole manufacturer and distributor of Cesium-131, a medical isotope currently used in brachytherapy for the treatment of prostate cancer. The reactor irradiation is a key step in the isotope …
-
- Idaho National Laboratory Supercharges Computing Bandwidth.
-
News wire article from: Europe Intelligence Wire
August 26, 2005
700+ words
-
- Idaho National Laboratory Director Appointed Chairman of Governor's Science &...
-
News wire article from: Europe Intelligence Wire
August 17, 2005
700+ words
-
- International Nuclear Energy Academy Elects Idaho National Laboratory Leader.
-
News wire article from: Europe Intelligence Wire
September 21, 2009
700+ words
-
- Idaho National Laboratory Launches Facebook Page.
-
News wire article from: Europe Intelligence Wire
September 8, 2009
700+ words
-
- OriginOil announces the completion of Phase I research project with...
-
News wire article from: Chemical Business Newsbase
October 7, 2009
700+ words
